Source: PharmaTech

Avista Pharma Solutions: Avista Pharma Acquires Solid Form Solutions

Avista Pharma Solutions expanded its solid-phase chemistry services with the acquisition of Solid Form Solutions on Jan. 23, 2018, adding solid state chemistry and crystallization development services for the pharmaceutical industry. The company now offers a suite of drug development servi

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Patrick D. Walsh's photo - CEO of Avista Pharma Solutions, Inc.

CEO

Patrick D. Walsh

CEO Approval Rating

86/100

Read more